AngioDynamics Inc at Barclays Global Healthcare Conference Transcript
(technical difficulty)
As well as Michael Greiner, who is the Chief Financial Officer.
So with that, we're going to have some slides that Jim is going to run through, and then we'll move into a little bit of a Q&A session. So without further ado, Jim?
Great. Thank you, Kristen, and thank you to Barclays. Thanks for the invitation to the conference. Again, my name is Jim Clemmer. I joined AngioDynamics nearly 3 years ago. I've spent nearly 30 years in the medical device industry, and I'll take the next few minutes and walk you through a bit about AngioDynamics that you may not know.
First, as you know, today, the words I'm going to say may not come true. So these are forward-looking statements we'll give you. We'll do the best of our ability to predict outcomes, but this is a tough business, and you guys are smart investors. So you'll know to take what we say with a breath of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
